200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 125313-92-0
CAS No: 125313-92-0 Catalog No: AG000NHI MDL No:
Title | Journal |
---|---|
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer. | Investigational new drugs 20120801 |
The first design and synthesis of [11C]MKC-1 ([11C]Ro 31-7453), a new potential PET cancer imaging agent. | Nuclear medicine and biology 20101001 |
A phase I clinical and pharmacokinetic study of Ro 31-7453 given as a 7- or 14-day oral twice daily schedule every 4 weeks in patients with solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20040701 |
© 2019 Angene International Limited. All rights Reserved.